..............page:348-354
..............page:317-323
..............page:375-380
A Study on the Long-term Non-small Cell Lung Cancer Survivors in the Expand Access Program of Gefitinib in China
Longyun LI1;Wei ZHONG1;Meilin LIAO2;Li CHEN3;Baohui HAN2;Zhongzhen GUAN4;Shiying YU5;Xuyi LIU6;Yilong WU7;Guoliang JIANG8;Jianming XU9;Jia CHEN10;Min TAO11;Rongcheng LUO12;Weimin LI13;Nong XU14;Xiao ZHAO1;Mengzhao WANG1 Li CHENof Medical Sciences;100730 Beijing;China;2Lung Tumor Clinical Medicine Center;Shanghai Chest Hospital;Shanghai Jiaotong University;200030 Shanghai;China;3Department of Oncology;Shandong Cancer Hospital;250117 Jinan;China;4Department of Medical Oncology;Sun Yat-Sen University Cancer Center;510060 Guangzhou;China;5Cancer Center;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;430030 Wuhan;China;6Department of Thoracic Medical Oncology;Peking University School of Oncology;Beijing Cancer Hospital and Institute;100142 Beijing;China;7Guangdong Institute and Cancer Center;Guangdong General Hospital;510080 Guangzhou;China;8Departments of Radiation Oncology;Fudan University Shanghai Cancer Center;200032 Shanghai;China;9Department of Oncology;Affiliated Hospital of Academy of Military Medical Sciences;100071 Beijing;China;10Department of Oncology;Jiangsu Cancer Hospital;210009 Nanjing;China;11Department of Oncology;the First Affiliated Hospital of Soochow University;215006 Suzhou;China;12Cancer Center;Nanfang Medical University Nanfang Hospital;510515 Guangzhou;China;13Department of Respiratory Diseases;West China Hospital;West China School of Medicine Sichuan University;610041 Chengdu;China;14Department of Chemotherapy;the First Affiliated Hospital of Medical School of Zhejiang University;310003 Hangzhou;China
..............page:332-339
..............page:324-331
..............page:386-390
..............page:369-374
..............page:361-368
..............page:381-385
..............page:355-360
..............page:340-347